AAAAAA
Results:
1-17
|
Results: 17
Authors:
Wikman, H
Thiel, S
Jager, B
Schmezer, P
Spiegelhalder, B
Edler, L
Dienemann, H
Kayser, K
Schulz, V
Drings, P
Bartsch, H
Risch, A
Citation: H. Wikman et al., Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility, PHARMACOGEN, 11(2), 2001, pp. 157-168
Authors:
Huber, H
Drings, P
Citation: H. Huber et P. Drings, On the occasion of the 65th birthday of Professor Wolfgang Queisser, ONKOLOGIE, 24(3), 2001, pp. 212-213
Authors:
Herth, F
Becker, HD
Manegold, C
Drings, P
Citation: F. Herth et al., Endobronchial ultrasound (EBUS) - Assessment of a new diagnostic tool in bronchoscopy for staging of lung cancer, ONKOLOGIE, 24(2), 2001, pp. 151-154
Authors:
Schmezer, P
Rajaee-Behbahani, N
Risch, A
Thiel, S
Rittgen, W
Drings, P
Dienemann, H
Kayser, KW
Schulz, V
Bartsch, H
Citation: P. Schmezer et al., Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes, MUTAGENESIS, 16(1), 2001, pp. 25-30
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer
Authors:
Rajaee-Behbahani, N
Schmezer, P
Risch, A
Rittgen, W
Kayser, KW
Dienemann, H
Schulz, V
Drings, P
Thiel, S
Bartsch, H
Citation: N. Rajaee-behbahani et al., Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer, INT J CANC, 95(2), 2001, pp. 86-91
Authors:
Lacroix, J
Becker, HD
Woerner, SM
Rittgen, W
Drings, P
Doeberitz, MV
Citation: J. Lacroix et al., Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR, INT J CANC, 92(1), 2001, pp. 1-8
Authors:
Sessa, C
Wanders, J
Roelvink, M
Dombernowsky, P
Nielsen, D
Morant, R
Drings, P
Wissel, P
Hanauske, AR
Citation: C. Sessa et al., Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG), ANN ONCOL, 11(2), 2000, pp. 207-210
Authors:
Drings, P
Stahel, R
Citation: P. Drings et R. Stahel, Status of topotecan in small-cell lung cancer, ONKOLOGIE, 23, 2000, pp. 1-1
Authors:
Drings, P
Citation: P. Drings, Concluding remarks, ONKOLOGIE, 23, 2000, pp. 18-20
Authors:
Gatzemeier, U
Kleisbauer, JP
Drings, P
Kaukel, E
Samaras, N
Melo, MJ
Cardenal, F
Robinet, G
Snijder, RJ
von Pawel, J
Palisses, R
Citation: U. Gatzemeier et al., Lenograstim as support for ACE chemotherapy of small-cell lung cancer - A phase III, multicenter, randomized study, AM J CL ONC, 23(4), 2000, pp. 393-400
Authors:
Fischer, JR
Schindel, M
Bulzebruck, H
Lahm, H
Krammer, PH
Drings, P
Citation: Jr. Fischer et al., Long-term survival in small cell lung cancer patients is correlated with high interleukin-2 secretion at diagnosis, J CANC RES, 126(12), 2000, pp. 730-733
Authors:
Wikman, H
Risch, A
Klimek, F
Schmezer, P
Spiegelhalder, B
Dienemann, H
Kayser, K
Schulz, V
Drings, P
Bartsch, H
Citation: H. Wikman et al., hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lungcancer susceptibility in a Caucasian population, INT J CANC, 88(6), 2000, pp. 932-937
Authors:
Drings, P
Manegold, C
Citation: P. Drings et C. Manegold, Differential indication of induction treatment in nonsmall-cell-lung-cancer, CHIRURG, 71(12), 2000, pp. 1466-1473
Authors:
Drings, P
Citation: P. Drings, Dyspnea in cancer patients, SUPP CARE C, 7(4), 1999, pp. 215-216
Authors:
Huinink, WWT
Bergman, B
Chemaissani, A
Dornoff, W
Drings, P
Kellokumpu-Lehtinen, PL
Liippo, K
Mattson, K
von Pawel, J
Ricci, S
Sederholm, C
Stahel, RA
Wagenius, G
von Walree, N
Manegold, C
Citation: Wwt. Huinink et al., Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer, LUNG CANC, 26(2), 1999, pp. 85-94
Authors:
Faller, H
Bulzebruck, H
Drings, P
Lang, H
Citation: H. Faller et al., Coping, distress, and survival among patients with lung cancer, ARCH G PSYC, 56(8), 1999, pp. 756-762
Authors:
Ebert, W
Drings, P
Citation: W. Ebert et P. Drings, Further comments. A clinical biologist's point of view - Concerning Rechnitzer S, et al: Pretreatment prognostic factors for survival in non-small-cell lung cancer: A multivariate analysis of 229 patients. Onkologie 1998;21: 204-210. Authors' reply, ONKOLOGIE, 21(6), 1998, pp. 511-511
Risultati:
1-17
|